Recombinant Torpedo californica Creatine kinase M-type

What is the basic structure and function of Torpedo californica creatine kinase?

Torpedo californica creatine kinase (TcCK) is an enzyme that catalyzes the reversible conversion of creatine and ATP to phosphocreatine and ADP, playing a crucial role in maintaining energy homeostasis in cells. The enzyme exists as a homodimer with a molecular weight of approximately 42,941 Da per monomer . The first high-resolution X-ray structure of TcCK bound to a transition-state analogue complex (CK-TSAC) was determined at 2.1 Å resolution, revealing important structural features related to substrate binding and catalysis .

The structure shows that in the active state, creatine is positioned with its guanidino nitrogen cis to the methyl group, oriented to perform an in-line attack at the γ-phosphate of ATP-Mg²⁺. Three ligands to Mg²⁺ are contributed by ADP and nitrate (in the crystal structure), with three additional ligands provided by ordered water molecules .

How does the active site of TcCK compare to other creatine kinase isoforms?

A striking feature observed in the TcCK transition-state analogue complex is the movement of two loops (residues 60-70 and 323-332) into the active site. This conformational change positions two hydrophobic residues, Ile69 and Val325, near the methyl group of creatine, creating a specificity pocket that is not present in the related enzyme arginine kinase . This specificity pocket likely explains the preferential binding of creatine over other guanidino substrates.

What are the optimal conditions for expressing recombinant TcCK in E. coli?

Recombinant TcCK can be expressed in E. coli BL21(DE3) cells using the pET17 expression vector . The optimal expression protocol involves:

• Transformation of the expression vector into E. coli BL21(DE3) cells

• Culture in Luria-Bertani medium containing appropriate antibiotics at 37°C

• Induction with IPTG when the culture reaches an OD600 of approximately 0.45

• Continued incubation for 5 hours at 37°C

• Harvesting cells by centrifugation

It's important to note that TcCK predominantly forms inclusion bodies in E. coli, resulting in insoluble protein aggregates with no detectable enzymatic activity . This necessitates specialized refolding procedures to obtain active enzyme.

What methods are effective for purifying active TcCK from inclusion bodies?

The purification of active TcCK from inclusion bodies involves a multi-step process that has been significantly improved over earlier methods. The most effective protocol includes:

• Dissolution of inclusion bodies in 8 M urea

• Extraction with Triton X-100 to remove proteolytic activity associated with the aggregates (this step is critical and improves recovery approximately 100-fold)

• Refolding by dialysis against Tris buffer (pH 8.0) containing 0.2 M NaCl

• Chromatography on Blue Sepharose as a final purification step

This optimized procedure yields approximately 54 mg of active protein from a 1 L culture with a specific activity of 75 U/mg . This represents a substantial improvement over earlier purification attempts that yielded less than 1 mg/L with a specific activity of only 5 U/mg.

What crystallization conditions have been successful for obtaining TcCK structures?

Successful crystallization of TcCK in complex with substrates or transition-state analogues has been achieved under the following conditions:

• Cocrystallization of the enzyme with ADP-Mg²⁺, nitrate, and creatine

• This approach yielded crystals of a homodimer where one monomer was bound to a transition-state analogue complex while the second monomer was bound to ADP-Mg²⁺ alone

• The crystals diffracted to 2.1 Å resolution

The resulting structure provided valuable insights into the enzyme's catalytic mechanism, particularly the conformational changes that occur upon substrate binding.

How can molecular dynamics simulations be applied to study TcCK catalytic mechanisms?

Molecular dynamics (MD) simulations can be effectively used to study the catalytic mechanism of creatine kinases like TcCK. Based on approaches used with the related human ubiquitous mitochondrial creatine kinase (uMtCK) , the following methodology can be applied:

• Generate a 3D structure of the TcCK- ATP-Mg²⁺- creatine complex using MD simulation methods

• Solvate the structure using TIP3P water molecules

• Perform energy minimization and extended MD simulations (typically 10+ ns) to remove bad contacts and achieve equilibration

• Analyze backbone root mean square deviation values to confirm structural stability

• Identify conformational changes, particularly in the flexible loops that move into the catalytic center upon substrate binding

• Use relaxed potential energy surface scans to search for reasonable transition-state structures

• Apply quantum mechanics calculations to determine the energy barriers for the phosphoryl transfer reaction

This computational approach revealed a two-step dissociative mechanism in uMtCK, with a calculated energy barrier of 16.3 kcal mol⁻¹ , and similar techniques could elucidate the detailed catalytic mechanism of TcCK.

What is the proposed catalytic mechanism for phosphoryl transfer in TcCK?

Based on structural and biochemical studies of TcCK and related enzymes, the phosphoryl transfer mechanism appears to follow a two-step dissociative pathway:

• First step: The substrate (creatine) delivers a guanidinium proton to a catalytic base in the enzyme (likely a glutamate residue analogous to E227 in human uMtCK)

• Second step: The γ-phosphate group of ATP transfers to creatine in a reversible reaction that forms ADP and phosphocreatine

The second step is the rate-determining step, with an energy barrier of approximately 16 kcal mol⁻¹ . The positioning of the substrates in the active site is critical, with the guanidino nitrogen of creatine aligned for an in-line attack on the γ-phosphate of ATP, facilitated by Mg²⁺ coordination.

How do the kinetic parameters of recombinant TcCK compare to those of native enzyme and other CK isoforms?

The kinetic parameters of refolded recombinant TcCK compared to human muscle creatine kinase (HMCK) are summarized in the following table:

These differences suggest that while the nucleotide binding sites are well-conserved between TcCK and HMCK, there are significant differences in the binding sites for the guanidino substrates .

How can site-directed mutagenesis of TcCK contribute to understanding phosphoryl transfer mechanisms?

Site-directed mutagenesis of TcCK can provide valuable insights into the roles of specific residues in substrate binding and catalysis. Based on approaches used with other creatine kinase isoforms, researchers should consider:

• Targeting residues in the conserved CPS motif (cysteine-proline-serine), which is known to be important for activity in human creatine kinases

• Investigating the role of the active site cysteine, which has been shown to have an unusually low pKa (~5.6) in human CK and interacts with creatine in the active site

• Mutating residues in the two flexible loops (60-70 and 323-332) that move into the active site upon substrate binding, particularly Ile69 and Val325 which form the specificity pocket for creatine

• Creating chimeric enzymes with related guanidino kinases like arginine kinase to investigate substrate specificity

Analysis of these mutants should include kinetic characterization, structural studies when possible, and computational simulations to understand the energetic consequences of the mutations.

What strategies can be employed to improve the stability and solubility of recombinant TcCK?

To improve the stability and solubility of recombinant TcCK for research applications, consider the following approaches:

• Fusion protein strategies: Express TcCK as a fusion with solubility-enhancing partners such as thioredoxin, SUMO, or MBP

• Co-expression with molecular chaperones like GroEL/GroES to aid proper folding

• Expression at reduced temperatures (15-25°C) and lower IPTG concentrations to slow protein synthesis and facilitate proper folding

• Addition of osmolytes or stabilizing agents (glycerol, arginine, trehalose) to the culture medium and purification buffers

• Protein engineering approaches: Introduction of surface mutations to enhance solubility while preserving the active site structure

• Exploration of alternative expression hosts such as yeast or insect cells that might produce more soluble protein

Combining these approaches may significantly improve the yield and quality of recombinant TcCK for structural and functional studies.

How does the structure of TcCK compare with creatine kinases from other species?

Comparative analysis of TcCK with other creatine kinases reveals both conserved features and important differences:

Understanding these similarities and differences can provide insights into the evolutionary conservation of creatine kinase function across species and help identify species-specific features that might be exploited in research or therapeutic applications.

What can comparative studies of different CK isoforms tell us about tissue-specific functions?

Comparative studies of TcCK with other CK isoforms (muscle, brain, and mitochondrial types) can reveal insights into their tissue-specific functions:

• Substrate affinity: Differences in Km values for creatine and phosphocreatine between isoforms may reflect tissue-specific energy requirements

• Catalytic efficiency: Variations in kcat/Km ratios could indicate adaptations to different cellular environments

• Regulatory mechanisms: Differential responses to pH, temperature, and cellular metabolites may reflect tissue-specific regulatory needs

• Protein-protein interactions: Isoform-specific interaction partners might explain localization patterns and functional integration with other cellular systems

These comparative analyses can help explain why different tissues express specific CK isoforms and how these enzymes have evolved to meet the unique energetic demands of their cellular environments.

How can researchers overcome proteolytic degradation during TcCK refolding?

Proteolytic degradation during TcCK refolding from inclusion bodies is a significant challenge that has been addressed through methodological innovations:

• Pre-extraction treatment: Extraction of inclusion bodies with a detergent-containing buffer prior to denaturation removes proteolytic activity associated with the aggregates, improving recovery approximately 100-fold

• Protease inhibitor limitations: Notably, the proteolytic activity associated with TcCK inclusion bodies is not effectively inhibited by conventional protease inhibitors like PMSF or EDTA

• Optimized refolding conditions: Quick dilution of denatured protein into refolding buffer can minimize exposure time and reduce proteolytic degradation

• Temperature control: Conducting refolding at 4°C can help reduce proteolytic activity

This issue appears to be a common problem with inclusion bodies, as similar proteolytic activity has been observed in aggregates of other proteins expressed in E. coli, such as bovine pancreatic trypsin inhibitor mutants .

What quality control methods are essential for verifying the structural integrity of recombinant TcCK?

To ensure the structural integrity and functional quality of recombinant TcCK preparations, researchers should employ the following quality control methods:

• Enzymatic activity assays: Measure specific activity using standard coupled enzyme assays for both forward and reverse reactions

• Circular dichroism (CD) spectroscopy: Compare the CD spectrum of refolded TcCK with native enzyme or HMCK to verify proper secondary structure formation

• Size exclusion chromatography: Confirm the homodimeric state of the enzyme and detect any aggregation

• Thermal stability analysis: Measure the melting temperature using differential scanning calorimetry or thermal shift assays

• Mass spectrometry: Verify the molecular mass and check for potential modifications or degradation products

• Limited proteolysis: Compare the proteolytic fragmentation pattern with that of native enzyme to assess tertiary structure integrity

These complementary approaches provide a comprehensive assessment of the structural and functional integrity of recombinant TcCK preparations, ensuring reliable results in subsequent experiments.

What emerging techniques could advance our understanding of TcCK structure and function?

Several emerging techniques hold promise for advancing our understanding of TcCK structure and function:

• Cryo-electron microscopy (cryo-EM): Could capture conformational states that are difficult to crystallize, particularly transient intermediates in the catalytic cycle

• Time-resolved X-ray crystallography: May allow visualization of structural changes during the phosphoryl transfer reaction

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Could provide insights into protein dynamics and conformational changes upon substrate binding

• Single-molecule FRET: May reveal the dynamics of loop movements and domain rearrangements during catalysis

• Advanced computational approaches: Integration of quantum mechanics/molecular mechanics (QM/MM) methods with enhanced sampling techniques could elucidate detailed reaction mechanisms

These techniques, alone or in combination, could address remaining questions about the precise sequence of events during catalysis, the role of protein dynamics, and the molecular basis of substrate specificity.

How might structural insights from TcCK inform therapeutic strategies targeting creatine kinases?

Structural insights from TcCK studies could inform therapeutic strategies targeting human creatine kinases in several ways:

• Identification of inhibitor binding sites: The detailed active site structure of TcCK provides a template for structure-based design of inhibitors that could be adapted to target human isoforms

• Understanding isoform specificity: Structural differences between TcCK and human isoforms could guide the development of isoform-selective inhibitors

• Allosteric regulation mechanisms: Identification of conformational changes and potential allosteric sites could lead to modulators that alter activity without directly competing with substrates

• Protein-protein interaction interfaces: Mapping of surface features involved in oligomerization or interactions with other cellular components could inform strategies to disrupt these interactions